Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Obstetrics & Gynecology|January 1, 1992
Iron balance in pregnancy in relation to anemiaN G Carretti, A G Eremita, D Paternoster, et al.
Clinical and Experimental Obstetrics & Gynecology|January 1, 1981
Fibrinogen degradation products (F.D.P.) in ascitic fluid of patients affected by ovarian cancerD Paternoster, T Maggino, S Valente, et al.
Clinical and Experimental Obstetrics & Gynecology|January 1, 1980
Modifications of the coagulation factors during normal and pathological pregnanciesD Paternoster, P Grella, P Canova, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 1, 1994
Clotting inhibitors and fibronectin as potential markers in preeclampsiaD Paternoster, A Stella, P Simioni, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1993
Erythropoietin and transferrin concentrations during pregnancy in relation to hemoglobin levelsN G Carretti, G A Eremita, B Porcelli, et al.
European Journal of Gynaecological Oncology|May 1, 1980
Acute reactive stage proteins in gynaecologic cancersD Paternoster, G Cartei, E Campagnutta, et al.
European Journal of Gynaecological Oncology|January 1, 1981
Fibrinolysis in ovarian cancerT Maggino, D Paternoster, S Valente, et al.
Clinical and Experimental Obstetrics & Gynecology|January 1, 1993
The significance of the relationship between serum levels of cobalamin and MCHC during pregnancyN G Carretti, A G Eremita, D Paternoster, et al.
British Journal of Obstetrics and Gynaecology|April 1, 1996
Hepatitis C virus infection in pregnancyA Floreani, D Paternoster, F Zappala, et al.
Pageof 3